The AZALEA-TIMI Trial
|
March 6, 2024 | Christian T. Ruff and C. Michael Gibson discuss the primary results of a randomized trial testing the efficacy of abelacimab versus rivaroxaban for stroke prevention in atrial fibrillation. |
TCTMD Talking Points
2024-03-06T14:00:00Z